Pacira BioSciences, Inc. (PCRX)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$27.52
+2.27%
Mkt Cap $1.06B
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (13 analysts)
$32.00
Range $32.00 – $32.00
Implied Upside
+16.3%
Consensus $32.00 vs current $27.52